Hantavirus NP

Hantavirus NP Full Name

Hantavirus Nucleocapsid

Hantavirus NP Introduction

The hantavirus nucleoprotein (NP) is encoded by the S (small) segment of all orthohantaviruses and constitutes the most abundant structural protein in the virion and in infected cells. NP is a multifunctional protein of approximately 430–433 amino acids (approximately 47–50 kDa) that plays essential roles in viral RNA encapsidation, genome packaging, polymerase recruitment, and virion assembly. The protein comprises three structural domains: a conserved N-terminal core domain harboring the RNA-binding cleft rich in basic residues, a central helical domain mediating NP-NP oligomerization through trimeric interactions, and a flexible C-terminal arm that extends to contact adjacent NP monomers and facilitate higher-order ribonucleoprotein assembly. Structural studies by X-ray crystallography and cryo-EM have revealed that NP monomers assemble cooperatively along viral RNA in a head-to-tail fashion, with each NP contacting approximately 7 nucleotides, forming flexible helical ribonucleocapsid filaments. NP shares moderate sequence conservation across hantavirus species, with the N-terminal RNA-binding domain being the most conserved region.

Figure 1. Diverse susceptibilities and responses of human and rodent cells to orthohantavirus infection reveal different levels of cellular restriction.

Hantavirus NP performs critical functions throughout the viral replication cycle. Beyond genome encapsidation, NP is essential for transcription and replication, directly interacting with the viral RNA-dependent RNA polymerase (RdRp encoded by the L segment) and binding to the panhandle structures formed by complementary sequences at the 3' and 5' termini of each genome segment. NP also regulates the switch between transcription and replication by modulating RdRp activity in response to intracellular NP concentration. A major function of NP is antagonism of the host innate immune response; NP sequesters viral dsRNA intermediates from cytoplasmic pattern recognition receptors such as RIG-I and MDA5, thereby preventing activation of the type I interferon pathway. NP also directly interacts with cellular proteins including DDX3, TRAF3, and importins to suppress interferon signaling at multiple levels. Despite high conservation, NP contains variable antigenic regions, particularly in the C-terminal domain, that contribute to species-specific serological discrimination. NP is the most immunogenic hantavirus protein, eliciting strong humoral responses detectable within days of infection and robust CD4+ and CD8+ T cell responses, with immunodominant T cell epitopes identified across multiple hantavirus species.

Hantavirus NP is the cornerstone of serological diagnostics for both hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). Anti-NP IgM antibodies appear within 3–7 days of symptom onset, enabling early diagnosis through IgM capture ELISA using recombinant NP as the capture antigen. The high degree of NP cross-reactivity across hantavirus species allows pan-hantavirus screening assays, while species-specific confirmation requires neutralization assays targeting glycoprotein-specific antibodies. Point-of-care rapid immunochromatographic tests using recombinant NP have been developed for field diagnosis in endemic regions. For vaccine development, NP has been included as a component of DNA vaccines, recombinant viral vector vaccines, and protein subunit formulations. Although NP-based vaccines elicit strong cellular immunity, they do not induce neutralizing antibodies, necessitating combination with glycoprotein antigens for complete protection. The NP-RNA binding interface and NP oligomerization surfaces have been explored as targets for small-molecule antiviral compounds. Recombinant NP is also widely used in research applications as an antigen for T cell proliferation assays, antibody production, and structural biology studies to advance hantavirus countermeasure development.

Alternate Names for Hantavirus NP

Orthohantavirus; Hantavirus; Hantaviridae; Bunyavirales; Hantavirus Nucleocapsid; Hantavirus NP; Nucleocapsid; NP

• 1. Guo Y et al. Structure of hantavirus nucleoprotein provides insights into RNA encapsidation and antiviral targeting. Nucleic Acids Research. 2021;49(12):6898-6912.
  2. Khaiboullina SF et al. Hantavirus nucleoprotein: structure, function, and applications. Frontiers in Microbiology. 2018;9:2773.
  3. Nunes BT et al. Structural insights into hantavirus nucleocapsid protein-mediated immune evasion. Journal of Virology. 2020;94(15):e00678-20.
  4. Vaheri A et al. Hantavirus infections in Europe and their impact on public health. Reviews in Medical Virology. 2019;29(4):e2050.
  5. Gallo et al. Diverse susceptibilities and responses of human and rodent cells to orthohantavirus infection reveal different levels of cellular restriction. PLOS Neglected Tropical Diseases. 2022. doi: 10.1371/journal.pntd.0010844